Argenx Se (ARGX) Current Leases (2019 - 2025)
Argenx Se (ARGX) posted Current Leases of $10.8 million for Q4 2025, down 99.97% on a QoQ basis from $35.6 billion in Q2 2025, and up 65.82% year-over-year from $6.5 million in Q4 2024.
Argenx Se (ARGX) Current Leases (2019 - 2025) Analysis & Trends
Argenx Se's Current Leases history runs 7 years deep, the most recent figure standing at $10.8 million for Q4 2025.
- Quarterly Current Leases rose 65.82% year-over-year to $10.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.8 million (up 65.82% YoY) and the FY2025 annual result came in at $10.8 million, up 65.82% from the prior year.
- Current Leases was $10.8 million for Q4 2025 at Argenx Se, down from $35.6 billion in the prior quarter.
- Across five years, Current Leases topped out at $35.6 billion in Q2 2025 and bottomed at $3.4 million in Q4 2022.
- A 5-year average of $3.6 billion and a median of $6.4 million in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases declined 2.62% — and 2025, when it soared 126444.99%.
- Argenx Se's Current Leases stood at $3.5 million in 2021, then dropped by 2.62% to $3.4 million in 2022, then jumped by 35.97% to $4.6 million in 2023, then surged by 40.62% to $6.5 million in 2024, then soared by 65.82% to $10.8 million in 2025.
- Business Quant data shows ARGX's Current Leases at $10.8 million in Q4 2025, $35.6 billion in Q2 2025, and $6.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 45.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.83 Mn |
| Jun 30, 2025 | 35.57 Bn |
| Dec 31, 2024 | 6.53 Mn |
| Jun 30, 2024 | 28.11 Mn |
| Dec 31, 2023 | 4.65 Mn |
| Jun 30, 2023 | 8.04 Mn |
| Dec 31, 2022 | 3.42 Mn |
| Jun 30, 2022 | 6.21 Mn |
| Dec 31, 2021 | 3.51 Mn |
| Jun 30, 2021 | 3.45 Mn |
| Dec 31, 2020 | 3.38 Mn |
| Jun 30, 2020 | 2.48 Mn |
| Dec 31, 2019 | 2.18 Mn |
| Jun 30, 2019 | 1.21 Mn |